Advertisement
ProteinSimple
ProteinSimple

The Scientist

» IP

Most Recent

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Opinion: Translation Nation

Opinion: Translation Nation

By | November 18, 2015

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

0 Comments

image: <em>TS</em> Picks: January 29, 2014

TS Picks: January 29, 2014

By | January 29, 2015

Celebrating lab techs; Myriad settles suits; publish in top-tier journals or perish

0 Comments

image: Keeping Up with IP

Keeping Up with IP

By | September 1, 2014

It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.

0 Comments

image: Yet Another Lawsuit over Genetic Tests

Yet Another Lawsuit over Genetic Tests

By | June 17, 2014

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

0 Comments

image: Week in Review: August 19–23

Week in Review: August 19–23

By | August 23, 2013

The importance of smORFs; America Invents Act and innovation in biotech; birds adjust their behavior to avoid cars; in defense of fundamental science

0 Comments

image: Opinion: AIA Does Not Discriminate

Opinion: AIA Does Not Discriminate

By | August 21, 2013

The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.

5 Comments

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: IP Lawsuits Settled

IP Lawsuits Settled

By | September 5, 2012

Two lawsuits against prominent researcher Craig Thompson for allegedly failing to share intellectual property with his institution lead to a licensing agreement on cancer diagnostics.

0 Comments

image: Opinion: On the Gene Patent Debate

Opinion: On the Gene Patent Debate

By | March 7, 2012

Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?

18 Comments

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
Advertisement
Life Technologies